India Markets closed
  • BSE SENSEX

    49,034.67
    -549.53 (-1.11%)
     
  • Nifty 50

    14,433.70
    -161.90 (-1.11%)
     
  • USD/INR

    73.1600
    +0.0200 (+0.0274%)
     
  • Dow

    30,814.26
    -177.24 (-0.57%)
     
  • Nasdaq

    12,998.50
    -114.10 (-0.87%)
     
  • BTC-INR

    2,654,793.00
    +38,098.25 (+1.46%)
     
  • CMC Crypto 200

    701.93
    -33.21 (-4.52%)
     
  • Hang Seng

    28,573.86
    +76.96 (+0.27%)
     
  • Nikkei

    28,519.18
    -179.12 (-0.62%)
     
  • EUR/INR

    88.3766
    -0.5798 (-0.65%)
     
  • GBP/INR

    99.3974
    -0.3551 (-0.36%)
     
  • AED/INR

    19.8740
    +0.0260 (+0.13%)
     
  • INR/JPY

    1.4161
    -0.0010 (-0.07%)
     
  • SGD/INR

    55.0230
    -0.1580 (-0.29%)
     

IndusInd Bank gains after promoters get Sebi nod for residual capital infusion

·1-min read

The Securities and Exchange Board of India (Sebi) has granted a further period of two weeks beyond the extension of one month granted earlier which was 4 February 2021. Accordingly, the extension has now been granted till 18 February 2021.

IndusInd Bank had issued convertible warrants to its promoters IndusInd International Holdings (IIHL) and its subsidiary IndusInd on 6 July 2019 under the composite scheme of arrangement for a total amount of Rs 2,695.26 crore for 1,57,70,985 share warrants. The promoters had paid Rs 673.82 crore towards warrant subscription for price – 25% of the warrant price of Rs 1,709 per share.

In view of the uncertain times due to the COVID-19 pandemic, the bank had at the request of IIHL and IL approached Sebi for extension in time for payment of the balance amount. The promoters in a letter to the bank have reiterated their commitment to the subscription to balance amount of warrants to complete the conversion into equity on or before 18 February.

IndusInd Bank caters to the needs of both consumer and corporate customers. It reported 53.2% decline in net profit to Rs 647.04 crore on 1.6% fall in total income to Rs 8,731.05 crore in Q2 FY21 over Q2 FY20.



Source: Capitalmarket.com